Literature DB >> 28779851

A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.

Migyung Lee1, Pejman Sehatpour2, Elisa C Dias2, Gail S Silipo3, Joshua T Kantrowitz2, Antigona M Martinez2, Daniel C Javitt2.   

Abstract

Deficits in mismatch negativity (MMN) generation are among the best replicated neurophysiological deficits in schizophrenia, with reduced amplitude reflecting impaired information processing at the level of supratemporal auditory cortex. Differential patterns of MMN dysfunction according to deviant types have been reported across studies, with some research groups showing impairment in duration MMN but not frequency MMN, and other research groups reporting both findings. We evaluate the hypothesis that recruitment setting, reflecting current functional status, might be an important determinant of the pattern of MMN dysfunction. Here, we evaluated patterns of MMN dysfunction, along with tone matching and neuropsychological performance in subjects drawn from 1) a predominant inpatient/residential care setting (Nathan Kline Institute) and 2) a predominant outpatient setting (Columbia University). As predicted, compared to healthy controls, deficits in duration MMN were observed across sites, whereas deficits in frequency MMN/tone matching were confined to the chronic inpatient setting. Within patients, the frequency MMN deficit was highly correlated with impairments in tone matching ability across sites (r=-0.52, p<0.0001), as well as impairments in verbal learning (r=-0.54, p<0.0001). Responses to standard stimuli in the MMN paradigm were assessed using measures of alpha evoked power and inter-trial coherence (ITC). While deficits in alpha ITC were observed across sites (both p<0.05), deficits in alpha power were observed at the inpatient (p=0.001) but not outpatient (p=0.2) site. Overall, these finding indicate that impairments of frequency MMN generation and response power to standard stimuli could be particularly linked to forms of schizophrenia that are associated with poor functional outcome.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive function; Functional outcome; Mismatch negativity; Schizophrenia; Time frequency analysis; Tone matching

Mesh:

Year:  2017        PMID: 28779851     DOI: 10.1016/j.schres.2017.07.032

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients.

Authors:  Joshua T Kantrowitz; Daniel C Javitt; Robert Freedman; Pejman Sehatpour; Lawrence S Kegeles; Marlene Carlson; Tarek Sobeih; Melanie M Wall; Tse-Hwei Choo; Blair Vail; Jack Grinband; Jeffrey A Lieberman
Journal:  Neuropsychopharmacology       Date:  2020-02-03       Impact factor: 7.853

2.  Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058.

Authors:  Pejman Sehatpour; Daniel C Javitt; Heloise M De Baun; Marlene Carlson; Anna Beloborodova; David H Margolin; Mark B L Carlton; Nicola L Brice; Joshua T Kantrowitz
Journal:  Neuropsychopharmacology       Date:  2021-10-20       Impact factor: 8.294

3.  Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.

Authors:  Antígona Martínez; Pablo A Gaspar; Steven A Hillyard; Søren K Andersen; Javier Lopez-Calderon; Cheryl M Corcoran; Daniel C Javitt
Journal:  Am J Psychiatry       Date:  2018-10-03       Impact factor: 18.112

4.  Abnormal Auditory Processing and Underlying Structural Changes in 22q11.2 Deletion Syndrome.

Authors:  Lucia-Manuela Cantonas; Valentina Mancini; Tonia A Rihs; Vincent Rochas; Maude Schneider; Stephan Eliez; Christoph M Michel
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

5.  Impact of baseline early auditory processing on response to cognitive remediation for schizophrenia.

Authors:  Alice Medalia; Alice M Saperstein; Min Qian; Daniel C Javitt
Journal:  Schizophr Res       Date:  2019-01-18       Impact factor: 4.939

6.  Auditory sensory memory span for duration is severely curtailed in females with Rett syndrome.

Authors:  Tufikameni Brima; Sophie Molholm; Ciara J Molloy; Olga V Sysoeva; Eric Nicholas; Aleksandra Djukic; Edward G Freedman; John J Foxe
Journal:  Transl Psychiatry       Date:  2019-04-09       Impact factor: 6.222

7.  Abnormal development of early auditory processing in 22q11.2 Deletion Syndrome.

Authors:  Lucia-Manuela Cantonas; Miralena I Tomescu; Marjan Biria; Reem K Jan; Maude Schneider; Stephan Eliez; Tonia A Rihs; Christoph M Michel
Journal:  Transl Psychiatry       Date:  2019-04-16       Impact factor: 6.222

8.  Deficits in Pre-attentive Processing of Spatial Location and Negative Symptoms in Subjects at Clinical High Risk for Schizophrenia.

Authors:  Pejman Sehatpour; Michael Avissar; Joshua T Kantrowitz; Cheryl M Corcoran; Heloise M De Baun; Gaurav H Patel; Ragy R Girgis; Gary Brucato; Javier Lopez-Calderon; Gail Silipo; Elisa Dias; Antigona Martinez; Daniel C Javitt
Journal:  Front Psychiatry       Date:  2021-02-02       Impact factor: 4.157

Review 9.  A roadmap for development of neuro-oscillations as translational biomarkers for treatment development in neuropsychopharmacology.

Authors:  Daniel C Javitt; Steven J Siegel; Kevin M Spencer; Daniel H Mathalon; L Elliot Hong; Antigona Martinez; Cindy L Ehlers; Atheir I Abbas; Tobias Teichert; Peter Lakatos; Thilo Womelsdorf
Journal:  Neuropsychopharmacology       Date:  2020-05-06       Impact factor: 8.294

10.  Bimodal distribution of tone-matching deficits indicates discrete pathophysiological entities within the syndrome of schizophrenia.

Authors:  Clément Dondé; Antigona Martínez; Joshua T Kantrowitz; Gail Silipo; Elisa C Dias; Gaurav H Patel; Juan Sanchez-Peña; Cheryl M Corcoran; Alice Medalia; Alice Saperstein; Blair Vail; Daniel C Javitt
Journal:  Transl Psychiatry       Date:  2019-09-06       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.